Intrinsic value of Teleflex - TFX

Previous Close

$255.92

  Intrinsic Value

$189.30

stock screener

  Rating & Target

sell

-26%

Previous close

$255.92

 
Intrinsic value

$189.30

 
Up/down potential

-26%

 
Rating

sell

We calculate the intrinsic value of TFX stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 11.7

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  15.40
  14.36
  13.42
  12.58
  11.82
  11.14
  10.53
  9.97
  9.48
  9.03
  8.63
  8.26
  7.94
  7.64
  7.38
  7.14
  6.93
  6.73
  6.56
  6.40
  6.26
  6.14
  6.02
  5.92
  5.83
  5.75
  5.67
  5.60
  5.54
  5.49
Revenue, $m
  2,477
  2,833
  3,213
  3,617
  4,045
  4,495
  4,968
  5,464
  5,982
  6,522
  7,085
  7,670
  8,279
  8,912
  9,569
  10,252
  10,963
  11,701
  12,469
  13,267
  14,098
  14,964
  15,865
  16,805
  17,784
  18,806
  19,873
  20,987
  22,150
  23,366
Variable operating expenses, $m
  1,938
  2,149
  2,376
  2,617
  2,872
  3,140
  3,422
  3,717
  4,026
  4,348
  4,221
  4,570
  4,932
  5,309
  5,701
  6,108
  6,531
  6,971
  7,429
  7,904
  8,399
  8,915
  9,452
  10,012
  10,595
  11,204
  11,840
  12,503
  13,197
  13,921
Fixed operating expenses, $m
  36
  37
  37
  38
  39
  40
  41
  42
  43
  44
  44
  45
  46
  47
  49
  50
  51
  52
  53
  54
  55
  56
  58
  59
  60
  62
  63
  64
  66
  67
Total operating expenses, $m
  1,974
  2,186
  2,413
  2,655
  2,911
  3,180
  3,463
  3,759
  4,069
  4,392
  4,265
  4,615
  4,978
  5,356
  5,750
  6,158
  6,582
  7,023
  7,482
  7,958
  8,454
  8,971
  9,510
  10,071
  10,655
  11,266
  11,903
  12,567
  13,263
  13,988
Operating income, $m
  503
  646
  799
  962
  1,134
  1,315
  1,506
  1,705
  1,913
  2,131
  2,819
  3,055
  3,300
  3,555
  3,820
  4,095
  4,381
  4,678
  4,987
  5,309
  5,644
  5,992
  6,355
  6,734
  7,129
  7,540
  7,970
  8,419
  8,888
  9,378
EBITDA, $m
  1,046
  1,200
  1,366
  1,541
  1,727
  1,923
  2,129
  2,344
  2,570
  2,805
  3,049
  3,304
  3,569
  3,844
  4,130
  4,428
  4,737
  5,058
  5,392
  5,740
  6,101
  6,478
  6,870
  7,279
  7,706
  8,151
  8,615
  9,100
  9,607
  10,137
Interest expense (income), $m
  44
  121
  153
  186
  222
  261
  301
  344
  388
  435
  484
  535
  588
  643
  701
  761
  823
  887
  954
  1,024
  1,097
  1,172
  1,251
  1,332
  1,418
  1,506
  1,599
  1,695
  1,796
  1,901
  2,011
Earnings before tax, $m
  382
  494
  613
  740
  873
  1,014
  1,162
  1,317
  1,478
  1,647
  2,284
  2,467
  2,657
  2,854
  3,059
  3,272
  3,493
  3,724
  3,963
  4,212
  4,471
  4,742
  5,023
  5,316
  5,622
  5,941
  6,275
  6,623
  6,987
  7,367
Tax expense, $m
  103
  133
  165
  200
  236
  274
  314
  356
  399
  445
  617
  666
  717
  771
  826
  883
  943
  1,005
  1,070
  1,137
  1,207
  1,280
  1,356
  1,435
  1,518
  1,604
  1,694
  1,788
  1,886
  1,989
Net income, $m
  279
  360
  447
  540
  638
  740
  848
  961
  1,079
  1,202
  1,668
  1,801
  1,939
  2,083
  2,233
  2,388
  2,550
  2,718
  2,893
  3,075
  3,264
  3,461
  3,667
  3,881
  4,104
  4,337
  4,581
  4,835
  5,100
  5,378

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  7,138
  8,163
  9,259
  10,424
  11,656
  12,955
  14,318
  15,746
  17,239
  18,795
  20,416
  22,104
  23,858
  25,682
  27,577
  29,546
  31,593
  33,720
  35,933
  38,234
  40,629
  43,123
  45,721
  48,428
  51,252
  54,197
  57,271
  60,481
  63,834
  67,338
Adjusted assets (=assets-cash), $m
  7,138
  8,163
  9,259
  10,424
  11,656
  12,955
  14,318
  15,746
  17,239
  18,795
  20,416
  22,104
  23,858
  25,682
  27,577
  29,546
  31,593
  33,720
  35,933
  38,234
  40,629
  43,123
  45,721
  48,428
  51,252
  54,197
  57,271
  60,481
  63,834
  67,338
Revenue / Adjusted assets
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
Average production assets, $m
  2,412
  2,759
  3,129
  3,523
  3,939
  4,378
  4,839
  5,322
  5,826
  6,352
  6,900
  7,471
  8,063
  8,680
  9,320
  9,986
  10,678
  11,397
  12,144
  12,922
  13,732
  14,575
  15,453
  16,368
  17,322
  18,317
  19,356
  20,441
  21,574
  22,759
Working capital, $m
  458
  524
  594
  669
  748
  832
  919
  1,011
  1,107
  1,207
  1,311
  1,419
  1,532
  1,649
  1,770
  1,897
  2,028
  2,165
  2,307
  2,454
  2,608
  2,768
  2,935
  3,109
  3,290
  3,479
  3,677
  3,883
  4,098
  4,323
Total debt, $m
  2,831
  3,453
  4,119
  4,826
  5,574
  6,362
  7,190
  8,057
  8,962
  9,907
  10,891
  11,915
  12,980
  14,087
  15,238
  16,433
  17,675
  18,967
  20,310
  21,707
  23,161
  24,674
  26,251
  27,895
  29,608
  31,396
  33,262
  35,210
  37,246
  39,373
Total liabilities, $m
  4,333
  4,955
  5,620
  6,327
  7,075
  7,863
  8,691
  9,558
  10,464
  11,409
  12,393
  13,417
  14,482
  15,589
  16,739
  17,934
  19,177
  20,468
  21,811
  23,208
  24,662
  26,176
  27,753
  29,396
  31,110
  32,897
  34,763
  36,712
  38,747
  40,874
Total equity, $m
  2,805
  3,208
  3,639
  4,096
  4,581
  5,091
  5,627
  6,188
  6,775
  7,386
  8,024
  8,687
  9,376
  10,093
  10,838
  11,612
  12,416
  13,252
  14,122
  15,026
  15,967
  16,947
  17,968
  19,032
  20,142
  21,299
  22,507
  23,769
  25,087
  26,464
Total liabilities and equity, $m
  7,138
  8,163
  9,259
  10,423
  11,656
  12,954
  14,318
  15,746
  17,239
  18,795
  20,417
  22,104
  23,858
  25,682
  27,577
  29,546
  31,593
  33,720
  35,933
  38,234
  40,629
  43,123
  45,721
  48,428
  51,252
  54,196
  57,270
  60,481
  63,834
  67,338
Debt-to-equity ratio
  1.010
  1.080
  1.130
  1.180
  1.220
  1.250
  1.280
  1.300
  1.320
  1.340
  1.360
  1.370
  1.380
  1.400
  1.410
  1.420
  1.420
  1.430
  1.440
  1.440
  1.450
  1.460
  1.460
  1.470
  1.470
  1.470
  1.480
  1.480
  1.480
  1.490
Adjusted equity ratio
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393
  0.393

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  279
  360
  447
  540
  638
  740
  848
  961
  1,079
  1,202
  1,668
  1,801
  1,939
  2,083
  2,233
  2,388
  2,550
  2,718
  2,893
  3,075
  3,264
  3,461
  3,667
  3,881
  4,104
  4,337
  4,581
  4,835
  5,100
  5,378
Depreciation, amort., depletion, $m
  542
  554
  566
  579
  593
  608
  623
  639
  656
  674
  230
  249
  269
  289
  311
  333
  356
  380
  405
  431
  458
  486
  515
  546
  577
  611
  645
  681
  719
  759
Funds from operations, $m
  821
  914
  1,014
  1,119
  1,231
  1,348
  1,472
  1,601
  1,735
  1,876
  1,898
  2,050
  2,208
  2,373
  2,544
  2,721
  2,906
  3,098
  3,298
  3,506
  3,722
  3,947
  4,182
  4,426
  4,682
  4,948
  5,226
  5,516
  5,819
  6,136
Change in working capital, $m
  61
  66
  70
  75
  79
  83
  88
  92
  96
  100
  104
  108
  113
  117
  122
  126
  131
  137
  142
  148
  154
  160
  167
  174
  181
  189
  197
  206
  215
  225
Cash from operations, $m
  760
  848
  943
  1,044
  1,152
  1,265
  1,384
  1,509
  1,640
  1,776
  1,793
  1,941
  2,095
  2,256
  2,422
  2,595
  2,775
  2,961
  3,156
  3,358
  3,568
  3,787
  4,015
  4,253
  4,500
  4,759
  5,028
  5,310
  5,604
  5,911
Maintenance CAPEX, $m
  -70
  -80
  -92
  -104
  -117
  -131
  -146
  -161
  -177
  -194
  -212
  -230
  -249
  -269
  -289
  -311
  -333
  -356
  -380
  -405
  -431
  -458
  -486
  -515
  -546
  -577
  -611
  -645
  -681
  -719
New CAPEX, $m
  -323
  -346
  -370
  -394
  -417
  -439
  -461
  -483
  -504
  -526
  -548
  -570
  -593
  -616
  -641
  -666
  -692
  -719
  -748
  -778
  -810
  -843
  -878
  -915
  -954
  -995
  -1,039
  -1,085
  -1,133
  -1,184
Cash from investing activities, $m
  -393
  -426
  -462
  -498
  -534
  -570
  -607
  -644
  -681
  -720
  -760
  -800
  -842
  -885
  -930
  -977
  -1,025
  -1,075
  -1,128
  -1,183
  -1,241
  -1,301
  -1,364
  -1,430
  -1,500
  -1,572
  -1,650
  -1,730
  -1,814
  -1,903
Free cash flow, $m
  368
  422
  481
  546
  618
  695
  777
  865
  958
  1,056
  1,034
  1,141
  1,253
  1,370
  1,492
  1,619
  1,750
  1,886
  2,028
  2,175
  2,328
  2,486
  2,651
  2,822
  3,001
  3,186
  3,379
  3,580
  3,789
  4,008
Issuance/(repayment) of debt, $m
  582
  622
  665
  707
  748
  788
  828
  867
  906
  945
  984
  1,024
  1,065
  1,107
  1,150
  1,195
  1,242
  1,291
  1,343
  1,397
  1,454
  1,514
  1,577
  1,643
  1,714
  1,788
  1,866
  1,948
  2,035
  2,127
Issuance/(repurchase) of shares, $m
  96
  43
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  678
  665
  665
  707
  748
  788
  828
  867
  906
  945
  984
  1,024
  1,065
  1,107
  1,150
  1,195
  1,242
  1,291
  1,343
  1,397
  1,454
  1,514
  1,577
  1,643
  1,714
  1,788
  1,866
  1,948
  2,035
  2,127
Total cash flow (excl. dividends), $m
  1,045
  1,086
  1,146
  1,254
  1,366
  1,483
  1,605
  1,732
  1,864
  2,001
  2,018
  2,165
  2,318
  2,477
  2,642
  2,814
  2,992
  3,178
  3,371
  3,572
  3,782
  4,000
  4,228
  4,466
  4,714
  4,974
  5,245
  5,528
  5,825
  6,135
Retained Cash Flow (-), $m
  -375
  -403
  -431
  -458
  -484
  -510
  -536
  -561
  -586
  -612
  -637
  -663
  -689
  -717
  -745
  -774
  -804
  -836
  -869
  -904
  -941
  -980
  -1,021
  -1,064
  -1,110
  -1,157
  -1,208
  -1,261
  -1,318
  -1,377
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  671
  683
  715
  796
  881
  973
  1,069
  1,171
  1,277
  1,389
  1,381
  1,502
  1,629
  1,761
  1,898
  2,040
  2,188
  2,342
  2,502
  2,668
  2,840
  3,020
  3,207
  3,402
  3,605
  3,816
  4,037
  4,267
  4,507
  4,758
Discount rate, %
  6.80
  7.14
  7.50
  7.87
  8.27
  8.68
  9.11
  9.57
  10.05
  10.55
  11.08
  11.63
  12.21
  12.82
  13.46
  14.14
  14.84
  15.59
  16.37
  17.18
  18.04
  18.94
  19.89
  20.89
  21.93
  23.03
  24.18
  25.39
  26.66
  27.99
PV of cash for distribution, $m
  628
  595
  576
  588
  593
  590
  581
  564
  540
  509
  435
  401
  364
  325
  285
  246
  208
  173
  140
  112
  87
  66
  49
  36
  25
  17
  12
  8
  5
  3
Current shareholders' claim on cash, %
  99.2
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9
  98.9

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM). The Company's products include oxygen therapy products, aerosol therapy products, spirometry products, and ventilation management products, which are offered under Hudson RCI brand. As of December 31, 2016, it manufactured its products at approximately 30 manufacturing sites, with manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States. Its all others businesses include single-use respiratory, urology and cardiac care products, as well as capital equipment.

FINANCIAL RATIOS  of  Teleflex (TFX)

Valuation Ratios
P/E Ratio 47.6
Price to Sales 6
Price to Book 5.3
Price to Tangible Book
Price to Cash Flow 27.6
Price to Free Cash Flow 31.8
Growth Rates
Sales Growth Rate 3.2%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -13.1%
Cap. Spend. - 3 Yr. Gr. Rate -3.7%
Financial Strength
Quick Ratio 3
Current Ratio 0
LT Debt to Equity 39.7%
Total Debt to Equity 48.3%
Interest Coverage 7
Management Effectiveness
Return On Assets 7.2%
Ret/ On Assets - 3 Yr. Avg. 6.8%
Return On Total Capital 7.6%
Ret/ On T. Cap. - 3 Yr. Avg. 7.3%
Return On Equity 11.4%
Return On Equity - 3 Yr. Avg. 11.3%
Asset Turnover 0.5
Profitability Ratios
Gross Margin 53.3%
Gross Margin - 3 Yr. Avg. 52.2%
EBITDA Margin 21.8%
EBITDA Margin - 3 Yr. Avg. 21.5%
Operating Margin 16.1%
Oper. Margin - 3 Yr. Avg. 16.2%
Pre-Tax Margin 13.2%
Pre-Tax Margin - 3 Yr. Avg. 12.9%
Net Profit Margin 12.7%
Net Profit Margin - 3 Yr. Avg. 12.1%
Effective Tax Rate 3.3%
Eff/ Tax Rate - 3 Yr. Avg. 6.6%
Payout Ratio 24.9%

TFX stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the TFX stock intrinsic value calculation we used $2146.303 million for the last fiscal year's total revenue generated by Teleflex. The default revenue input number comes from 0001 income statement of Teleflex. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our TFX stock valuation model: a) initial revenue growth rate of 15.4% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 6.8%, whose default value for TFX is calculated based on our internal credit rating of Teleflex, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Teleflex.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of TFX stock the variable cost ratio is equal to 81.1%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $35 million in the base year in the intrinsic value calculation for TFX stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for Teleflex.

Corporate tax rate of 27% is the nominal tax rate for Teleflex. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the TFX stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for TFX are equal to 97.4%.

Life of production assets of 67.9 years is the average useful life of capital assets used in Teleflex operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for TFX is equal to 18.5%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $2430.531 million for Teleflex - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 45.796 million for Teleflex is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Teleflex at the current share price and the inputted number of shares is $11.7 billion.

RELATED COMPANIES Price Int.Val. Rating
BDX Becton Dickins 235.24 1,279.12  str.buy
MMSI Merit Medical 57.80 1.24  str.sell
ANGO AngioDynamics 20.60 9.05  str.sell
JNJ Johnson&Johnso 144.25 176.79  buy

COMPANY NEWS

▶ Teleflex: 3Q Earnings Snapshot   [06:57AM  Associated Press]
▶ Teleflex Announces Quarterly Dividend   [06:45AM  Business Wire]
▶ Teleflex Reports Third Quarter 2018 Results   [06:30AM  Business Wire]
▶ Teleflex Acquires Essential Medical   [Oct-04-18 05:00PM  Business Wire]
▶ 5 Things to Know About Teleflex Stock   [Sep-19-18 07:00AM  InvestorPlace]
▶ Teleflex (TFX) Q2 Earnings Surpass Estimates   [Aug-02-18 10:40AM  Zacks]
▶ Teleflex: 2Q Earnings Snapshot   [09:33AM  Associated Press]
▶ Teleflex Announces Quarterly Dividend   [06:45AM  Business Wire]
▶ Teleflex Reports Second Quarter 2018 Results   [06:30AM  Business Wire]
▶ Stock Upgrades: Teleflex Shows Rising Relative Strength   [May-24-18 03:00AM  Investor's Business Daily]
▶ Teleflex Incorporated Hosts Analyst & Investor Day   [May-11-18 09:00AM  Business Wire]
▶ Teleflex Announces Quarterly Dividend   [May-07-18 06:45AM  Business Wire]
▶ Teleflex: 1Q Earnings Snapshot   [May-03-18 06:47AM  Associated Press]
▶ Teleflex Reports First Quarter 2018 Results   [06:30AM  Business Wire]
▶ Edited Transcript of TFX presentation 7-Mar-17 8:25pm GMT   [Apr-10-18 03:28PM  Thomson Reuters StreetEvents]
▶ Teleflex reports 4Q loss   [Feb-22-18 06:57AM  Associated Press]
▶ Teleflex Announces Quarterly Dividend   [06:45AM  Business Wire]
▶ Top-Rated Stocks: Teleflex Sees Composite Rating Climb To 96   [Jan-03-18 03:00AM  Investor's Business Daily]
▶ ETFs with exposure to Teleflex, Inc. : December 27, 2017   [Dec-27-17 11:54AM  Capital Cube]
▶ US troops get freeze-dried plasma for battlefield bloodshed   [Nov-30-17 04:07PM  Associated Press]
▶ ETFs with exposure to Teleflex, Inc. : November 17, 2017   [Nov-17-17 01:03PM  Capital Cube]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.